Translational neuroscience : : toward new therapies / / edited by Karoly Nikolich and Steven E. Hyman ; Program Advisory Committee, Steven E. Hyman, Julia Lupp, Robert C. Malenka, Karoly Nikolich, Menelas N. Pangalos, and Bernd Sommer.

Today, translational neuroscience faces significant challenges. Available therapies to treat brain and nervous system disorders are extremely limited and dated, and further development has effectively ceased. Disinvestment by the private sector occurred just as promising new technologies in genomics...

Full description

Saved in:
Bibliographic Details
Superior document:Strungmann forum reports
TeilnehmendeR:
Place / Publishing House:Cambridge, MA : : The MIT Press,, [2015]
Year of Publication:2015
Edition:1st ed.
Language:English
Series:Strüngmann Forum reports.
Physical Description:1 online resource (319 p.)
Notes:Description based upon print version of record.
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 04397cam a2200745Ii 4500
001 993547434904498
005 20240418013034.0
006 m o d
007 cr#cnu||||||||
008 150826s2015 maua ob 001 0 eng d
020 |a 0-262-32986-7 
020 |a 0-262-32985-9 
035 |a (CKB)3710000000465899 
035 |a (EBL)3433803 
035 |a (SSID)ssj0001542972 
035 |a (PQKBManifestationID)16132156 
035 |a (PQKBTitleCode)TC0001542972 
035 |a (PQKBWorkID)14791867 
035 |a (PQKB)10527999 
035 |a (StDuBDS)EDZ0001530664 
035 |a (OCoLC)919201534 
035 |a (MdBmJHUP)muse47289 
035 |a (OCoLC)919201534  |z (OCoLC)960929265  |z (OCoLC)1055368403  |z (OCoLC)1066446165  |z (OCoLC)1066668520  |z (OCoLC)1076713843  |z (OCoLC)1081250004 
035 |a (OCoLC-P)919201534 
035 |a (MaCbMITP)10460 
035 |a (Au-PeEL)EBL3433803 
035 |a (CaPaEBR)ebr11093305 
035 |a (CaONFJC)MIL826829 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/78538 
035 |a (MiAaPQ)EBC3433803 
035 |a (EXLCZ)993710000000465899 
040 |a OCoLC-P  |b eng  |e rda  |e pn  |c OCoLC-P 
041 |a eng 
050 4 |a RC337  |b .T729 2015eb 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616.80072  |2 23 
245 0 0 |a Translational neuroscience :  |b toward new therapies /  |c edited by Karoly Nikolich and Steven E. Hyman ; Program Advisory Committee, Steven E. Hyman, Julia Lupp, Robert C. Malenka, Karoly Nikolich, Menelas N. Pangalos, and Bernd Sommer. 
250 |a 1st ed. 
264 1 |a Cambridge, MA :  |b The MIT Press,  |c [2015] 
300 |a 1 online resource (319 p.) 
336 |a text  |b txt 
337 |a computer  |b c 
338 |a online resource  |b cr 
490 1 |a Strungmann forum reports 
500 |a Description based upon print version of record. 
505 0 |a Intro; Contents; The Ernst Strüngmann Forum; List of Contributors; 1 - Introduction; Neurodevelopmental Disorders: A New Beginning; Neurodegenerative Diseases:Coming Unstuck; New Tools to Drive Future Therapies; From Cellular and Animal Models to Patients; Epilogue; Bibliography; Subject Index; 2 - What Do We Know about Early Onset Neurodevelopmental Disorders?; 3 - Psychotic Disorders and the Neurodevelopmental Continuum; 4 - Neurodevelopmental Disorders; 5 - Neurodegenerative Diseases; 6 - Preclinical and Clinical Understanding; 7 - Neurodegenerative Diseases 
505 8 |a 8 - How Might We Get from Genes to Circuits to Disease?9 - How Do We Define and Modulate Circuits in Animals That Are Relevant to Pathophysiology in Humans?; 10 - Pathophysiological Toolkit; 11 - Using a Stem Cell-Based Approach to Model Neurodegenerative Disease; 12 - From Rodent Behavioral Models to Human Disorders; 13 - Bridging the Gap between Patients and Models; 14 - The Revolution Has Begun 
546 |a English 
521 |a Specialized. 
504 |a Includes bibliographical references and index. 
520 8 |a Today, translational neuroscience faces significant challenges. Available therapies to treat brain and nervous system disorders are extremely limited and dated, and further development has effectively ceased. Disinvestment by the private sector occurred just as promising new technologies in genomics, stem cell biology, and neuroscience emerged to offer new possibilities. In this volume, experts from both academia and industry discuss how novel technologies and reworked translation concepts can create a more effective translational neuroscience. The contributors consider such topics as using genomics and neuroscience for better diagnostics and biomarker identification; new approaches to disease based on stem cell technology and more careful use of animal models; and greater attention to human biology and what it will take to make new therapies available for clinical use. 
588 |a OCLC-licensed vendor bibliographic record. 
650 0 |a Neurosciences  |x Research. 
650 0 |a Nervous system  |x Diseases. 
650 0 |a Drug development. 
653 |a NEUROSCIENCE/General 
653 |a BIOMEDICAL SCIENCES/General 
776 |z 0-262-02986-3 
700 1 |a Nikolich, Karoly. 
700 1 |a Hyman, Steven E. 
830 0 |a Strüngmann Forum reports. 
906 |a BOOK 
ADM |b 2024-04-20 04:28:21 Europe/Vienna  |f system  |c marc21  |a 2015-09-06 00:20:29 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338572960004498&Force_direct=true  |Z 5338572960004498  |b Available  |8 5338572960004498